http://community.advanceweb.com/blogs/al_1/archive/2009/04/29/screening-for-ovarian-cancer-with-biomarkers-are-we-there-yet.aspxCA-125 is used mainly to monitor patients with ovarian cancer (OC), in part due to the low level of sensitivity when CA-125 is used alone. In an effort to improve the early detection of OC while keeping the number of false positives low (higher specificity),enCommunityServer 2.1 SP2 (Debug Build: 61120.2)